Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
71.86
+2.68 (3.87%)
At close: Mar 9, 2026, 4:00 PM EDT
70.51
-1.35 (-1.88%)
After-hours: Mar 9, 2026, 7:43 PM EDT
Inhibrx Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,045 | 223 | - | - | - |
| Enterprise Value | 999 | 28 | - | - | - |
| Last Close Price | 71.86 | 15.40 | - | - | - |
| PE Ratio | - | 0.13 | - | - | - |
| PS Ratio | 746.51 | 1114.65 | - | - | - |
| PB Ratio | 28.29 | 1.67 | - | - | - |
| P/TBV Ratio | 28.38 | 1.67 | - | - | - |
| EV/Sales Ratio | 713.52 | 142.16 | - | - | - |
| Debt / Equity Ratio | 2.90 | 0.06 | 4.83 | -0.69 | 1.35 |
| Net Debt / Equity Ratio | -1.25 | -1.08 | -1.56 | -0.69 | -1.16 |
| Net Debt / EBITDA Ratio | 0.24 | 0.55 | 0.31 | -0.04 | - |
| Net Debt / FCF Ratio | 0.32 | 0.73 | 0.34 | -0.05 | - |
| Asset Turnover | 0.01 | 0.00 | 0.01 | 0.02 | - |
| Inventory Turnover | 55.38 | 34.28 | 35.84 | - | - |
| Quick Ratio | 4.28 | 3.76 | 4.95 | 0.01 | 5.85 |
| Current Ratio | 4.49 | 3.94 | 5.25 | 0.30 | 6.20 |
| Return on Equity (ROE) | -144.07% | 1905.92% | -1333.38% | -511.61% | - |
| Return on Assets (ROA) | -60.97% | -67.38% | -84.42% | -86.27% | - |
| Return on Capital Employed (ROCE) | -137.90% | -188.10% | -87.10% | 2794.40% | -59.80% |
| Earnings Yield | -14.84% | 757.00% | - | - | - |
| FCF Yield | -13.72% | -88.37% | - | - | - |
| Buyback Yield / Dilution | -6.72% | -27.17% | 70.62% | -5.52% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.